Latest news from the Sting world.
View this email in your browser
Sting launches: Sting Incubate Deeptech
We're happy to announce a new track within our Incubate program supporting early-stage companies based on complex technologies. The aim is to better support the early-stage deeptech companies that have great potential to solve major, important global problems but often have a longer path to market. The program is designed in collaboration with KTH Innovation to offer tailored coaching for 24 months from knowledgeable people in deeptech, such as Jane Walerud, Mårten Skogö, Ulrika Nordén, Patrik Möller & Björn Westerholm.
Sting company highlights
Sting highlights
Savvy tech profile Hannah Meiton joins Sting
Sting strengthens its team and recruits Hannah Meiton, former COO of Soundtrack your brand and VP Sales at iZettle. Hannah has many years of experience developing software companies, primarily in Silicon Valley. At Sting, Hannah will be coaching the Sting companies and sharpen their growth and metrics strategies.
More news from the Sting world
Propel Capital, Sweden’s most active private investor in early stages, raises 25 MSEK from 42 experienced business angels and Saminvest. Since its inception in 2014, Propel Capital I, II, III and IV have invested SEK 34 million in 113 Sting companies. 
Mindmore, the company developing neurocognitive tests, raises 7,5 MSEK from Propel Capital investors and Almi Invest among others. The investment will be used to further develop its service and to further expand in Sweden. 
imagiLabs, the programming community for teenage girls, was selected as the winner of this year's European Youth Award in the Smart Learning category. The company also got selected to represent Sweden at the German Marshall Fund of the United States in Washington, D.C.
Life science company iCellate Medical launches a new service, genetic cancer screening, that will help doctors to analyze tumor cells in the blood and gives a complete picture of the patient without any surgical intervention. This helps doctors to set the right treatment for diagnosed cancer patients early on.
 Upcoming events Open Positions in Sting companies 
Connect with us!
Sting Partners 
Copyright © 2019 Sting - Stockholm Innovation & Growth, All rights reserved.

unsubscribe from this list    update subscription preferences